Evidence for a wide extra-astrocytic distribution of S100B in human brain
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: S100B is considered an astrocytic in-situ marker and protein levels in cerebrospinal fluid (CSF) or serum are often used as biomarker for astrocytic damage or dysfunction. However, studies on S100B in the human brain are rare. Thus, the distribution of S100B was studied by immunohistochemistry in adult human brains to evaluate its cell-type specificity. RESULTS: Contrary to glial fibrillary acidic protein (GFAP), which selectively labels astrocytes and shows only faint ependymal immunopositivity, a less uniform staining pattern was seen in the case of S100B. Cells with astrocytic morphology were primarily stained by S100B in the human cortex, while only 20% (14-30%) or 14% (7-35%) of all immunopositive cells showed oligodendrocytic morphology in the dorsolateral prefrontal and temporal cortices, respectively. In the white matter, however, most immunostained cells resembled oligodendrocytes [frontal: 75% (57-85%); temporal: 73% (59-87%); parietal: 79% (62-89%); corpus callosum: 93% (86-97%)]. S100B was also found in ependymal cells, the choroid plexus epithelium, vascular endothelial cells, lymphocytes, and several neurones. Anti-myelin basic protein (MBP) immunolabelling showed an association of S100B with myelinated fibres, whereas GFAP double staining revealed a distinct subpopulation of cells with astrocytic morphology, which solely expressed S100B but not GFAP. Some of these cells showed co-localization of S100B and A2B5 and may be characterized as O2A glial progenitor cells. However, S100B was not detected in microglial cells, as revealed by double-immunolabelling with HLA-DR. CONCLUSION: S100B is localized in many neural cell-types and is less astrocyte-specific than GFAP. These are important results in order to avoid misinterpretation in the identification of normal and pathological cell types in situ and in clinical studies since S100B is continuously used as an astrocytic marker in animal models and various human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · cited 1×
“This may have arisen from several postmortem studies on Alzheimer's disease and Down's syndrome describing predominant S100B immunostaining in reactive astrocytes surrounding neuritic plaques [14-16].”
BackgroundA soluble protein characteristic of the nervous system
Moore, B. W. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90320-7 · Cited by 1,695
Donato, R. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00046-2 · Cited by 1,580 · cited 3×
“Immunocytochemical studies detected S100B in 5–25% of CD8+ peripheral blood T cells [41], in adipose tissue, melanocytes, injured myocardium, satellite cells of dorsal root ganglia and Schwann-cells of the peripheral nervous system [2].”
BackgroundPhysiological and Biochemical Aspects of Nervous Integration
Carlson, F. D. (1968) · Cited by 747
Hsu, S. M., & Soban, E. (1982) · Journal of Histochemistry & Cytochemistry · doi:10.1177/30.10.6182185 · Cited by 659
Histology and Histopathology of the Nervous System
Moossy, J. (1982) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198209000-00010 · Cited by 424
S100β Induces Neuronal Cell Death Through Nitric Oxide Release from Astrocytes
Hu, J., Ferreira, A., & Van Eldik, L. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062294.x · Cited by 336
Wunderlich, M. T., Ebert, A. D., Kratz, T., Goertler, M., Jost, S., & Herrmann, M. (1999) · Stroke · doi:10.1161/01.str.30.6.1190 · Cited by 251
Mrak, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00293-7 · Cited by 248
Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization
Steiner, J., Mawrin, C., Ziegeler, A., Bielau, H., Ullrich, O., Bernstein, H.-G., & Bogerts, B. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0090-8 · Cited by 229
Self-citation
Cited by
Verkhratsky, A., & Nedergaard, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2016 · Cited by 1,678
“In the CNS it is expressed not only in astroglia but also in oligodendrocytes, in ependymal cells, in the choroid plexus epithelium, in vascular endothelial cells, in lymphocytes, and in some neurons (1664), in particular in neurons in the brain stem, cerebellum, forebrain, and the limbic system (1466).”
Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603
“In the gray matter, this protein is predominantly expressed and secreted by astrocytes, while oligodendrocytes expressed S100B in white matter [90-92].”
BackgroundAstrocyte Heterogeneity: Impact to Brain Aging and Disease
Matias, I., Morgado, J., & Gomes, F. C. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00059 · Cited by 387
Ependymal cells: biology and pathology
Del Bigio, M. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0624-y · Cited by 386
Astrocyte phenotype in relation to Alzheimer‐type pathology in the ageing brain
Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C., & Wharton, S. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.015 · Cited by 381
SOX9 Is an Astrocyte-Specific Nuclear Marker in the Adult Brain Outside the Neurogenic Regions
Sun, W., Cornwell, A., Li, J., Peng, S., Osorio, M. J., Aalling, N., Wang, S., Benraiss, A., Lou, N., Goldman, S. A., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3199-16.2017 · Cited by 357
“In addition, S100 has been shown to label astrocytes, but it is also expressed by oligodendrocytes and their progenitors (Steiner et al., 2007).”
BackgroundThelin, E. P., Nelson, D. W., & Bellander, B.-M. (2017) · Acta Neurochirurgica · doi:10.1007/s00701-016-3046-3 · Cited by 317
Blood-Brain Barrier Overview: Structural and Functional Correlation
Alahmari, A. (2021) · Neural Plasticity · doi:10.1155/2021/6564585 · Cited by 299
“As a result, the quantity of cBMECs in the blood may be a good indicator of BBB degradation degree [98].”
BackgroundLeclerc, E., Fritz, G., Weibel, M., Heizmann, C. W., & Galichet, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703951200 · Cited by 262
Gonçalves, C.-A., Concli Leite, M., & Nardin, P. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.04.003 · Cited by 255
Stratification of astrocytes in healthy and diseased brain
Verkhratsky, A., Zorec, R., & Parpura, V. (2017) · Brain Pathology · doi:10.1111/bpa.12537 · Cited by 236
“At the same time immunoreactivity for S100B is detected in other CNS cells including oligodendrocytes, ependymal cells, choroid plexus epithelium, vascular endothelial cells, and even in some neurones (199, 237).”
BackgroundGarwood, C. J., Ratcliffe, L. E., Simpson, J. E., Heath, P. R., Ince, P. G., & Wharton, S. B. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12338 · Cited by 233
Structural Remodeling of Astrocytes in the Injured CNS
Sun, D., & Jakobs, T. C. (2012) · The Neuroscientist · doi:10.1177/1073858411423441 · Cited by 219
Undén, J., & Romner, B. (2010) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0b013e3181e57e22 · Cited by 178
Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke
Bonaventura, A., Liberale, L., Vecchié, A., Casula, M., Carbone, F., Dallegri, F., & Montecucco, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17121967 · Cited by 166
“Among them, the release of calcium-binding proteins S100B has been traditionally ascribed to astrocyte dysfunction, but recent studies rather indicate a role as a marker of BBB injury [188,189].”
BackgroundSerum markers support disease-specific glial pathology in major depression
Schroeter, M. L., Abdul-Khaliq, H., Krebs, M., Diefenbacher, A., & Blasig, I. E. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.005 · Cited by 152
Oades, R. D., Dauvermann, M. R., Schimmelmann, B. G., Schwarz, M. J., & Myint, A.-M. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-29 · Cited by 151
Gos, T., Schroeter, M. L., Lessel, W., Bernstein, H.-G., Dobrowolny, H., Schiltz, K., Bogerts, B., & Steiner, J. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.005 · Cited by 106
Self-citationKobayashi, E., Nakano, M., Kubota, K., Himuro, N., Mizoguchi, S., Chikenji, T., Otani, M., Mizue, Y., Nagaishi, K., & Fujimiya, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-19442-7 · Cited by 98
Du, J., Yi, M., Zhou, F., He, W., Yang, A., Qiu, M., & Huang, H. (2021) · Molecular Brain · doi:10.1186/s13041-021-00865-9 · Cited by 57
“Consistent with the previous reports that S100B is primarily expressed by glial cells [5, 24, 26], the vast majority of S100B+ cells do not co-express neuronal marker NeuN in the spinal cord tissue (Fig.”
ResultAbnormal development of the inferior temporal region in fetuses with Down syndrome
Guidi, S., Giacomini, A., Stagni, F., Emili, M., Uguagliati, B., Bonasoni, M. P., & Bartesaghi, R. (2018) · Brain Pathology · doi:10.1111/bpa.12605 · Cited by 47
Güleş, E., Iosifescu, D. V., & Tural, Ü. (2020) · Neuropsychobiology · doi:10.1159/000505782 · Cited by 42
Wang, C.-H., Gu, J.-Y., Zhang, X.-L., Dong, J., Yang, J., Zhang, Y.-L., Ning, Q.-F., Shan, X.-W., & Li, Y. (2016) · Behavioral and Brain Functions · doi:10.1186/s12993-016-0116-x · Cited by 33
Sinha, S., Patro, N., Tiwari, P. K., & Patro, I. K. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104877 · Cited by 28
Steiner, J., Bernstein, H.-G., Schiltz, K., Haase, T., Meyer-Lotz, G., Dobrowolny, H., Müller, U. J., Martins-de-Souza, D., Borucki, K., Schroeter, M. L., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.10.001 · Cited by 13
“S100B protein expression is not astrocyte- or oligodendrocyte-specific, but has also been observed in Schwann cells, ependymal cells, choroid plexus epithelia, and a few neurons (Steiner et al., 2007).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Steiner, J., Bernstein, H.-G., Bielau, H., Berndt, A., Brisch, R., Mawrin, C., Keilhoff, G., & Bogerts, B.
- Venue
- BMC Neuroscience
- Published
- 2007-01-02
- Volume
- 8
- Issue
- 1
- Pages
- 2-2
- ISSN
- 1471-2202 (ISSN-L)
- OpenAlex
- W2103360825
- Cited by
- 283
- References
- 48
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.